Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,995 | 41,795 | 44,726 | 65,581 | 23,054 |
| Marketable Securities | 129,669 | 156,350 | 167,353 | 163,955 | 74,156 |
| Receivables | 304 | 217 | 405 | N/A | 5,000 |
| Other current assets | 0 | 2,100 | 2,100 | 273 | 126 |
| TOTAL | $181,562 | $202,255 | $216,715 | $231,176 | $103,544 |
| Non-Current Assets | |||||
| PPE Net | 2,905 | 90 | 90 | 103 | 69 |
| Other Non-Current Assets | 2,280 | 1,363 | 1,363 | 980 | 634 |
| TOTAL | $5,185 | $1,453 | $1,453 | $1,083 | $703 |
| Total Assets | $186,747 | $203,708 | $218,168 | $232,259 | $104,247 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,219 | 3,108 |
| Accounts payable and accrued liabilities | 1,973 | 1,629 | 1,336 | 2,075 | 1,354 |
| Accrued Expenses | 8,588 | 2,437 | 2,071 | 4,976 | 2,828 |
| Other current liabilities | N/A | N/A | 5,632 | 7,648 | 6,091 |
| TOTAL | $14,415 | $13,640 | $16,916 | $17,918 | $16,310 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 2,142 | 2,990 |
| Other Non-Current Liabilities | 1,914 | 0 | 0 | 0 | 0 |
| TOTAL | $1,914 | $1,937 | $2,039 | $2,142 | $2,990 |
| Total Liabilities | $16,329 | $15,577 | $18,955 | $20,060 | $19,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,470 | 59,439 | 59,053 | 58,769 | 58,502 |
| Common Shares | 6 | 6 | 6 | 6 | 4 |
| Retained earnings | -523,064 | -503,615 | -485,052 | -467,521 | -450,516 |
| Other shareholders' equity | -58 | -31 | -67 | -132 | -44 |
| TOTAL | $170,418 | $188,131 | $199,213 | $212,199 | $84,947 |
| Total Liabilities And Equity | $186,747 | $203,708 | $218,168 | $232,259 | $104,247 |